PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498781
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498781
Dissolution Equipment Market size was valued at USD 641.09 million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.
The rising need for pharmaceuticals, propelled by factors including aging populations as well as the prevalence of chronic illnesses, fuels the need for dissolution testing, thereby boosting the market. Increased research and development activities in the pharmaceutical industry, particularly in the development of novel drug formulations, require extensive dissolution testing, stimulating market growth. In some emerging markets, there may be limited awareness or adoption of dissolution testing standards and equipment due to varying regulatory frameworks or resource constraints.
Dissolution Equipment Market- Market Dynamics
Increasing demand for pharmaceuticals driving the dissolution equipment market
As the demand for pharmaceuticals rises, driven by factors such as population growth, aging demographics, and the prevalence of chronic diseases, there's a corresponding need for efficient and reliable dissolution testing equipment. Pharmaceutical companies invest in advanced dissolution equipment to streamline their drug development processes, ensure compliance with regulatory standards, and maintain product quality. These advancements in drug development necessitate specialized dissolution equipment capable of accommodating diverse formulations and providing accurate data for formulation optimization and regulatory submissions. According to the data, In 2023, the total global pharmaceutical market was estimated at around 1.6 trillion U.S. dollars.
Dissolution Equipment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)
Based on product type segmentation, Automated Dissolution Equipment was predicted to show maximum market share in the year 2023
Based on end-user segmentation, Pharmaceutical Companies were the leading type in 2023
Based on application segmentation, Drug Release Testing was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Dissolution Equipment Market is segmented on the basis of Product Type, Application, End User, Technology, and Region.
The market is divided into two categories based on product type: Manual Dissolution Equipment, and Automated Dissolution Equipment. Automation ensures that dissolution tests are conducted with a high level of precision and consistency, reducing variability in results caused by human error. Automation helps ensure that dissolution tests are conducted in accordance with regulatory standards and guidelines, enhancing compliance with requirements set by organizations such as the FDA. Automated dissolution equipment can streamline dissolution testing processes, improve data quality, and enhance productivity in pharmaceutical development and quality control laboratories.
The market is divided into four categories based on application: Pharmaceutical Companies, Contract Research Organizations (CROs), Academic & Research Institutes, and Others. Dissolution testing is a critical part of quality control in pharmaceutical manufacturing. It ensures that solid oral dosage forms, such as tablets and capsules, release their active pharmaceutical ingredients (APIs) in a consistent and reproducible manner, which is essential for ensuring product efficacy and safety. Pharmaceutical companies must conduct dissolution testing as per regulatory guidelines to demonstrate product quality and performance.
Dissolution Equipment Market- Geographical Insights
The market for dissolving equipment is dominated by North America. The existence of large pharmaceutical corporations and substantial R&D spending support this supremacy. There is a consistent demand for dissolving testing equipment since the United States is a major contributor, providing significant funding for pharmaceutical research. Increased investments in medication development and a strong presence of major pharmaceutical companies support the market in the region. Furthermore, the market for dissolving equipment is expanding quickly in the Asia-Pacific area. Leading the way are nations like China, India, and Japan, propelled by rising investments in pharmaceutical manufacture and research and development.
Major players in the dissolution equipment market includes Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Sotax AG, Pharma Test Apparatebau AG, Labindia Instruments Pvt Ltd., etc. Sotax AG is known for high-quality products and strong customer support. A major player known for its advanced dissolution testing instruments and software solutions. Agilent's strong R&D capabilities and global presence make it a significant competitor. SOTAX is specialized in dissolution testing systems and offers a range of automated solutions. SOTAX is recognized for its high-quality products and focus on innovation. Companies that ensure compliance with these standards can gain a competitive edge. Adherence to regulatory standards such as those set by the FDA, EMA, and other global health authorities is crucial. Companies are investing heavily in R&D to develop advanced dissolution equipment with features like automation, real-time analysis, and enhanced data management capabilities.
In June 2023, In the area of dissolution testing, Mettler Toledo and Sotax announced a new collaboration. The leading maker of apparatus for assessing the dissolution of pharmaceutical dosage forms, Sotax is headquartered in Switzerland.
GLOBAL DISSOLUTION EQUIPMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Sotax AG
Distek, Inc.
Erweka GmbH
Hanson Research Corporation
Pharma Test Apparatebau AG
Copley Scientific Ltd.
Electrolab India Pvt Ltd.
Labindia Instruments Pvt Ltd.
Others